{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:53:03Z","timestamp":1780332783948,"version":"3.54.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.atherosclerosis.2008.03.011","type":"journal-article","created":{"date-parts":[[2008,3,21]],"date-time":"2008-03-21T14:11:15Z","timestamp":1206108675000},"page":"248-256","source":"Crossref","is-referenced-by-count":16,"title":["The endocannabinoid system and cardiometabolic risk"],"prefix":"10.1016","volume":"199","author":[{"given":"Paul E.","family":"Szmitko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib1","unstructured":"World Health Organization. Obesity and Overweight Fact Sheet No. 311; 2006. http:\/\/www.who.int\/mediacentre\/factsheets\/fs311\/en\/print.html [accessed September 8, 2007]."},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib2","doi-asserted-by":"crossref","unstructured":"Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case\u2013control study. Lancet 2005;366:1640\u20139","DOI":"10.1016\/S0140-6736(05)67663-5"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib3","doi-asserted-by":"crossref","first-page":"H2031","DOI":"10.1152\/ajpheart.01058.2004","article-title":"Adipokines: molecular links between obesity and atheroslcerosis","volume":"288","author":"Lau","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib4","doi-asserted-by":"crossref","first-page":"H1655","DOI":"10.1152\/ajpheart.01072.2006","article-title":"Adiponectin and cardiovascular disease","volume":"292","author":"Szmitko","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1210\/er.2005-0009","article-title":"The emerging role of the endocannabinoid system in endocrine regulation and energy balance","volume":"27","author":"Pagotto","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib6","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-2999(03)01295-0","article-title":"Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a \u201cCB3\u201d receptor","volume":"461","author":"Fride","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1054\/plef.2001.0342","article-title":"Molecular biology of cannabinoid receptors","volume":"66","author":"Lutz","year":"2002","journal-title":"Prostaglandins Leukot. Essent Fatty Acids"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib12","first-page":"297","article-title":"Nonclassical cannabinoid analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model","volume":"33","author":"Howlett","year":"1988","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib13","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1046\/j.1471-4159.2001.00333.x","article-title":"Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus","volume":"77","author":"Derkinderen","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1089\/dna.1997.16.301","article-title":"Induction of interleukin-2 receptor alpha gene by delta9-tetrahydrocannabinoid is mediated by nuclear factor kappaB and CBI cannabinoid receptor","volume":"16","author":"Daaka","year":"1997","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib15","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1124\/mol.58.4.814","article-title":"The CB1 cannabinoid receptor is coupled to the activation of c-JUN N-terminal kinase","volume":"58","author":"Rueda","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib16","doi-asserted-by":"crossref","first-page":"36527","DOI":"10.1074\/jbc.M205797200","article-title":"Cannabinoids protect astrocytes from ceramide-induced apoptosis through the phosphatidylinositol 3-kinase\/protein kinase B pathway","volume":"277","author":"Gomez Del Pulgar","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib17","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib18","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","article-title":"Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity","volume":"115","author":"Osei-Hyiaman","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib19","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/gut.48.6.859","article-title":"Cannabinoids and the gastrointestinal tract","volume":"48","author":"Pertwee","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ceca.2005.10.005","article-title":"Cannabinoid receptors regulate Ca2+ signals and insulin secretion in pancreatic \u03b2-cell","volume":"39","author":"Juan-Pico","year":"2005","journal-title":"Cell Calcium"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1172\/JCI17725","article-title":"The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis","volume":"112","author":"Cota","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib22","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1042\/0264-6021:3460835","article-title":"Functional CB1 cannabinoid receptors in human vascular endothelial cells","volume":"346","author":"Liu","year":"2000","journal-title":"Biochem J"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib23","first-page":"H2085","article-title":"Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current","volume":"266","author":"Gebremedhin","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1115740","article-title":"Identification and functional characterization of brainstem cannabinoid CB2 receptors","volume":"310","author":"Van Sickle","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00418-005-0127-4","article-title":"Presence of the cannabinoid receptors, CB1 and CB2, in human omental and subcutaneous adipocytes","volume":"126","author":"Roche","year":"2006","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib26","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1096\/fj.02-0795fje","article-title":"Inhibition of tumour angiogenesis by cannabinoids","volume":"17","author":"Blazquez","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0163-7258(02)00257-7","article-title":"Tetrahyrocannabinol and endocannabinoids in feeding and appetite","volume":"95","author":"Berry","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0031-9384(98)00170-X","article-title":"Hyperphagia in prefed rats following oral \u03949-THC","volume":"65","author":"Williams","year":"1998","journal-title":"Physiol Behav"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0091-3057(01)00694-3","article-title":"Reversal of \u03949-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine","volume":"71","author":"Williams","year":"2002","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00427475","article-title":"Effects of marihuana use on body weight and caloric intake in humans","volume":"49","author":"Greenberg","year":"1976","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0091-3057(86)90144-9","article-title":"Behavioral analysis of marijuana effects on food intake in humans","volume":"25","author":"Foltin","year":"1986","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib32","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130050953","article-title":"Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors","volume":"143","author":"Williams","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib33","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.bjp.0704767","article-title":"Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol","volume":"136","author":"Kirkham","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib34","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35071088","article-title":"Leptin-regulated endocannabinoids are involved in maintaining food intake","volume":"410","author":"Di Marzo","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib35","doi-asserted-by":"crossref","first-page":"L113","DOI":"10.1016\/S0024-3205(98)00322-1","article-title":"Appetite suppression and weight loss after the cannabinoid antagonist SR141716","volume":"63","author":"Colombo","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib36","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1124\/mol.63.4.908","article-title":"The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa\/fa rats and in cultured adipocyte cells","volume":"63","author":"Bensaid","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib37","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/sj.ijo.0802583","article-title":"CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity","volume":"28","author":"Ravinet-Trillou","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib38","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1096\/fj.04-3177fje","article-title":"The CB1 receptor antagonist rimonabant reverses the diet-induced obesity phenotype through the regulation of lipolysis and energy balance","volume":"19","author":"Jbilo","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib39","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.2337\/diabetes.54.10.2838","article-title":"Activation of the peripheral endocannabinoid system in human obesity","volume":"54","author":"Engeli","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib40","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/sj.ijo.0803539","article-title":"Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men","volume":"31","author":"Cote","year":"2007","journal-title":"Int J Obese (Lond)"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib41","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.2337\/db06-0812","article-title":"Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity","volume":"55","author":"Bluher","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib42","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.ijo.0802954","article-title":"Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)","volume":"29","author":"Sipe","year":"2005","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib43","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.ijo.0803510","article-title":"Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population","volume":"31","author":"Gazzero","year":"2007","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib44","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.neuropharm.2004.12.005","article-title":"Blood pressure regulation by endocannabinoids and their receptors","volume":"48","author":"Pacher","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib45","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-2999(95)00181-J","article-title":"Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamide","volume":"278","author":"Varga","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib46","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1126\/science.283.5400.401","article-title":"Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice","volume":"383","author":"Ledent","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib47","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00210-003-0755-y","article-title":"The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression","volume":"367","author":"Niederhoffer","year":"2003","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib48","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI119677","article-title":"physiological actions of anandamide in the vasculature of the rat kidney","volume":"100","author":"Deutsch","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib49","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1096\/fasebj.12.11.1035","article-title":"Platelet- and macrophage-derived endogenouscannabinoids are involved in endotoxin-induced hypotension","volume":"12","author":"Varga","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib50","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/37371","article-title":"Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock","volume":"390","author":"Wagner","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib51","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/S0735-1097(01)01671-0","article-title":"Endogenous cannabinoids mediate hypotension after experimental myocardial infarction","volume":"38","author":"Wagner","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib52","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/01.CIR.0000143230.23252.D2","article-title":"Endocannabinoids acting at CB1 receptors regulate cardiovascular function in hypertension","volume":"110","author":"Batkai","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib53","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1161\/01.CIR.0000089190.95415.9F","article-title":"New markers of inflammation and endothelial cell activation","volume":"108","author":"Szmitko","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib54","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nature03389","article-title":"Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice","volume":"434","author":"Steffens","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib55","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ncpcardio0504","article-title":"Does cannabis hold the key to treating cardiometabolic disease?","volume":"3","author":"Szmitko","year":"2006","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib56","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1055\/s-2006-925401","article-title":"Cannabinoid receptor signaling directly inhibits thermogenesis and alters expression of adiponectin and visfatin","volume":"38","author":"Perwitz","year":"2006","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib57","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1124\/mol.63.4.908","article-title":"The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa\/fa rats in cultured adipocyte cells","volume":"63","author":"Bensaid","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib58","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000087925","article-title":"Cocaine- and amphetamine-related transcript peptide is involved in the orexigenic effect of endogenous anandamide","volume":"81","author":"Osei-Hyiaman","year":"2005","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0140-6736(07)60033-6","article-title":"Drug treatments for obesity: orlistat, sibutramine, and rimonabant","volume":"369","author":"Padwal","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib60","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients. RIO-North America: a randomized controlled trial","volume":"295","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib61","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib62","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib63","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0140-6736(06)69571-8","article-title":"Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes","volume":"368","author":"Scheen","year":"2006","journal-title":"Lancet"},{"issue":"Suppl. 2","key":"10.1016\/j.atherosclerosis.2008.03.011_bib64","doi-asserted-by":"crossref","first-page":"S229","DOI":"10.2337\/dc08-s258","article-title":"Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight\/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program","volume":"31","author":"Van Gaal","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib65","unstructured":"FDA Briefing Document. NDA 21-888. Zimulti (rimonabant) Tablets, 20mg. Sanofi Aventis. Advisory Committee; June 2007, Available at: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/07\/briefing\/2007-4306b1-fda-backgrounder.pdf[accessed September 8, 2007]."},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib66","unstructured":"STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant\u2014the Intravascular Ultrasound Study), Available at:http:\/\/www.clinicaltrials.gov\/ct\/show\/NCT00124332?order=5 [accessed September 8, 2007]."},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib67","unstructured":"CRESCENDO (Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints) and Outcomes, Available at: http:\/\/www.clinicaltrials.gov\/ct\/show\/NCT00263042?order=2 [accessed September 8, 2007]."},{"key":"10.1016\/j.atherosclerosis.2008.03.011_bib68","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.299.13.1547","article-title":"Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial","volume":"299","year":"2008","journal-title":"JAMA"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915008001676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915008001676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T05:47:53Z","timestamp":1684302473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915008001676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0021915008001676"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.03.011","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}